You are here

Clinical Trials: Vascular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, March 23, 2021 - 12:00
Condition:   Ischemic Stroke
Interventions:   Biological: Umbilical Cord-derived Mesenchymal Stem Cells;   Drug: Placebo
Sponsor:   General Hospital of Shenyang Military Region
Posted: Monday, March 1, 2021 - 12:00
Conditions:   Diabetes Mellitus;   Ischemic Heart Disease
Interventions:   Drug: 100 million Allogeneic Mesenchymal Human Stem Cells;   Other: Placebo
Sponsors:   Joshua M Hare;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Posted: Thursday, January 28, 2021 - 12:00
Conditions:   Myocardial Infarction;   Heart Diseases
Intervention:   Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor:   Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Posted: Tuesday, November 17, 2020 - 12:00
Condition:   Ischemic Stroke
Intervention:   Biological: Neural Stem Cells
Sponsor:   Gary Steinberg
Not yet recruiting
Posted: Thursday, October 29, 2020 - 12:00
Condition:   Acute Ischemic Stroke
Interventions:   Biological: JTR-161;   Biological: Placebo
Sponsor:   Teijin Pharma Limited
Posted: Wednesday, October 28, 2020 - 12:00
Condition:   Healing Potentiality After Regeneration Using Standard PRF and Advanced PRF in Mature Necrotic Single Teeth
Intervention:   Procedure: Advanced Platelet Rich fibrin
Sponsor:   Cairo University
Not yet recruiting
Posted: Monday, October 19, 2020 - 12:00
Condition:   Ischemic Stroke
Interventions:   Drug: it-hMSC;   Drug: Placebo
Sponsors:   Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.;   Beijing Tiantan Hospital
Not yet recruiting
Posted: Tuesday, September 29, 2020 - 12:00
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle Sheet
Sponsor:   Anterogen Co., Ltd.
Posted: Thursday, September 24, 2020 - 12:00
Conditions:   Cardiovascular Diseases;   Cardiovascular Risk Factor;   Triglycerides High;   Diabetes Mellitus, Type 2
Intervention:   Drug: Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
Sponsors:   Canadian Medical and Surgical Knowledge Translation Research Group;   HLS Therapeutics, Inc;   St. Michael's Hospital, Toronto;   University of Western Ontario, Canada
Not yet recruiting
Posted: Wednesday, September 16, 2020 - 12:00
Condition:   Acute Myocardial Infarction
Interventions:   Biological: Intravenous infusion placebo;   Biological: Intravenous infusion WJMSCs
Sponsors:   Navy General Hospital, Beijing;   Peking University Third Hospital;   Peking Union Medical College Hospital;   Xijing Hospital;   Chinese PLA General Hospital
Not yet recruiting